Many women perceive financial barriers to cervical cancer screening

Among low-income, uninsured, or publicly insured women ages 25-64 years who were not up to date on cervical cancer screening, 72% perceived financial barriers to screening. The most commonly reported barriers were screening appointment costs (71%) and follow-up/future treatment costs (44%), according to a study published in the peer-reviewed Journal of Women's Health.

Screening is effective at reducing the incidence of and mortality associated with cervical cancer. However, disparities exist in cervical cancer incidence and mortality and in cervical cancer screening based on poverty level, insurance status, race, and ethnicity. Only about 64% of uninsured women, 78% of publicly insured women, and 75% of low-income women have been screened in accordance with national screening guidelines. Perceived financial barriers to screening likely affect cervical cancer screening adherence.

"Most notably, this study illustrates the importance of the availability and awareness of health. Insurance and other financial resources to reduce perceived financial barriers to screening," state Jennifer Smith, PhD, University of North Carolina, and coauthors of the study. "Insurance status heavily influences the actual out-of-pocket costs incurred from the cervical cancer screening appointment and labs, which may influence perceived cost burden and barriers."

Low-income women need greater access to insurance coverage options, Medicaid eligibility, or free screening programs so they can undergo regular cervical cancer screening without perceived financial barriers to care."

Susan G. Kornstein, MD, Journal of Women's Health Editor-in-Chief, Executive Director of the Virginia Commonwealth University Institute for Women's Health, Richmond, VA

Source:
Journal reference:

Biddell, C.B., et al. (2021) Perceived Financial Barriers to Cervical Cancer Screening and Associated Cost Burden Among Low-Income, Under-Screened Women. Journal of Women's Health. doi.org/10.1089/jwh.2020.8807.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New blood test detects early lung damage in cancer patients on targeted therapy